Appesat - A new way to curb appetite?

This week, the website Nursing in Practice reported that a company called Goldshield has launched a new product to help dieters feel full up when reducing their calorie intake.

Goldshield states that Appesat works in a different way to other appetite suppressants on the market by staying in the stomach for longer.

The results in clinical studies have been positive. One clinical trial found that by taking just 3 Appesat capsules 3 times a day, overweight and obese people, lost an average of 9.4kg (20.7lb) in 12 weeks compared with 5.6kg (12.4lb) among people in the control group not taking the drug.

The product claims to train people to eat less so that maintaining a healthy weight becomes easier to achieve once the period of dieting is over.

The manufactures say that the product, Appesat, is made from seaweed extracts. It expands the stomach and stimulates hunger sensors, sending a message to the brain that the stomach is full.

New Study Says Weight Control Important Factor In Avoiding Disability in Later Life

According to lead researcher Dr. Denise Houston, an assistant professor of gerontology at Wake Forest University School of Medicine in Winston-Salem, North Carolina, people who are overweight or obese in young adulthood and middle-age are at an increased risk of being disabled in their later years.

In her study, of more than 2,800 U.S. adults in their 70s, Dr Houston found that those who were overweight or obese at any point in adulthood had an increased risk of developing problems with walking and climbing stairs.

What's more, the longer a person had been overweight, the greater his or her risk of mobility limitations, the researchers report in the American Journal of Epidemiology.

Dr Houston's findings highlight the importance of preventing excessive weight gain early in life.

Read the Full Article on Yahoo News